Correlation between hemodynamic changes and tomographic sestamibi imaging during dipyridamole-induced coronary hyperemia

Journal of the American College of Cardiology

Volumn 31, Issue 1, 1998, Pages 75-82

  Ogilby, J David ^a   Kegel, Jeffrey G ^a   Heo, Jaekyeong ^a   Iskandrian, Ami E ^a  

^a Med Coll P   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORRELATION FUNCTION; FEMALE; HEART MUSCLE PERFUSION; HEMODYNAMICS; HUMAN; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THERMODILUTION;

ADULT; AGED; BLOOD PRESSURE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIPYRIDAMOLE; FEMALE; HEART DISEASES; HEMODYNAMIC PROCESSES; HUMANS; HYPEREMIA; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PULMONARY WEDGE PRESSURE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 0031884585     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00448-8     Document Type: Article

References (38)

1. Iskandrian AS, Heo J, Askenase A, Segal BL, Auerbach N. Dipyridamole cardiac imaging. Am Heart J. 115:1988;432-443.
2. Homma S, Gilliland Y, Guiney TE, Strauss HW, Boucher CA. Safety of intravenous dipyridamole for stress testing with thallium imaging. Am J Cardiol. 59:1987;1542-1544.
3. Ranhosky A, Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging Intravenous Dipyridamole Thallium Imaging Study Group . Circulation. 81:1990;1205-1209.
4. Bolognese L, Sarasso G, Aralda D, Bongo AS, Rossi L, Rossi P. High dose dipyridamole echocardiography early after uncomplicated acute myocardial infarction correlation with exercise testing and coronary angiography . J Am Coll Cardiol. 14:1989;357-363.
5. Gimple LW, Hutter AM Jr, Guiney TE, Boucher CA. Prognostic utility of predischarge dipyridamole thallium imaging compared to predischarge submaximal exercise electrocardiography and maximal exercise thallium imaging after uncomplicated acute myocardial infarction. Am J Cardiol. 64:1989;1243-1248.
6. Leppo JA, O'Brian J, Rothendler JA, Getchell JD, Lee VW. Dipyridamole thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med. 310:1984;1014-1018.
7. Pirelli S, Inglese E, Suppa M, Corrada E, Campolo L. Dipyridamole thallium-201 scintigraphy in the early post-infarction period. Eur Heart J. 9:1988;1324-1331.
8. Boucher CA, Brewster DC, Darling RC, Okada RD, Strauss HW, Pohost GM. Determination of cardiac risk by dipyridamole thallium imaging before peripheral vascular surgery. N Engl J Med. 312:1985;389-394.
9. Eagle KA, Singer DE, Brewster DC, Darling RC, Mulley AG, Boucher CA. Dipyridamole thallium scanning in patients undergoing vascular surgery optimizing preoperative evaluation of cardiac risk . JAMA. 257:1987;2185-2189.
10. Leppo J, Plaja J, Gionet M, Tumolo J, Paraskos JA, Cutler BS. Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol. 9:1987;269-276.
11. Levinson JR, Boucher CA, Coley CM, Guiney TE, Strauss HW, Eagle KA. Usefulness of semiquantitative analysis of dipyridamole thallium-201 redistribution for stratification before vascular surgery. Am J Cardiol. 66:1990;406-410.
12. Beller GA. Pharmacologic stress imaging. JAMA. 265:1991;633-638.
13. Iskandrian AS, Heo J. Pharmacologic stress testing. In: BL Zarat, GA Beller, editors. Nuclear Cardiology: State of the art and future directions. St. Louis: Mosby, 1993:170-80.
14. Möser GH, Schrader J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol. 256:(4 Pt. 1):1989;c799-c806.
15. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev. 70:1990;761-845.
16. Ogilby JD, Iskandrian AS, Unterecker WJ, Heo J, Nguyen TN, Mercuro J. Effect of intravenous adenosine infusion on myocardial perfusion and function hemodynamic/angiographic study . Circulation. 86:1992;887-895.
17. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease. J Am Coll Cardiol. 14:1989;77-86.
18. Feldman RL, Nichols WW, Pepine CJ, Conti CR. Acute effect of intravenous dipyridamole on regional coronary hemodynamics and metabolism. Circulation. 64:1981;333-344.
19. Granato JE, Watson DD, Belardinelli L, Cannon JM, Beller GA. Effects of dipyridamole and aminophylline on hemodynamics, regional myocardial blood flow and thallium-201 washout in the setting of a critical coronary stenosis. J Am Coll Cardiol. 16:1990;1760-1770.
20. Iskandrian AS, Verani MS, Heo J. Pharmacologic stress testing mechanism of action, hemodynamic responses, and results in detection of coronary artery disease . J Nucl Cardiol. 1:1994;94-111.
21. Kahn D, Argenyi EA, Berbaum K, Rezai K. The incidence of serious hemodynamic changes in physically-limited patients following oral dipyridamole challenge before thallium-201 scintigraphy. Clin Nucl Med. 15:1990;678-682.
22. Kern MJ, Deligonul U, Tatineni S, Serota H, Aguirre F, Hilton TC. Intravenous adenosine continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease . J Am Coll Cardiol. 18:1991;718-729.
23. Miller DD, Scott RA, Reismeter JS, et al. Acute hemodynamic changes during intravenous dipyridamole thallium imaging early after infarction. Am Heart J. 118:1989;686-694.
24. Nishimura S, Kimball KT, Mahmarian JJ, Verani MS. Angiographic and hemodynamic determinants of myocardial ischemia during adenosine thallium-201 scintigraphy in coronary artery disease. Circulation. 87:1993;1211-1219.
25. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human arterial circulation. Circulation. 82:1990;1595-1606.
26. Biaggioni I, Onrot J, Hollister AS, Robertson D. Cardiovascular effects of adenosine infusion in man and their modulation of dipyridamole. Life Sci. 39:1986;2229-2236.
27. Costa F, Biaggioni I. Adenosine activates afferent fibers in the forearm, producing sympathetic stimulation in humans. J Pharmacol Exp Ther. 267:1993;1369-1374.
28. McLaughlin DP, Beller GA, Linden J, et al. Hemodynamic and metabolic correlates of dipyridamole-induced myocardial thallium-201 perfusion abnormalities in multivessel coronary artery disease. Am J Cardiol. 73:1994;1159-1164.
29. 1 adenosine receptor-mediated effects in humans Circulation. 93:1996;1871-1876.
30. Shen WK, Hammill SC, Munger TM, et al. Adenosine potential modulator for vasovagal syncope . J Am Coll Cardiol. 28:1996;146-154.
31. Taillefer R, Amyot R, Turpin S, Lambert R, Pilon C, Jarry M. Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging. J Nucl Cardiol. 3:1996;204-211.
32. Czernin J, Auerbach M, Sun KT, Phelps M, Schelbert MR. Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. J Nucl Med. 36:1995;575-580.
33. Ren JF, Pancholy SB, Kegel JG, Lighty GW Jr, Heo J, Iskandrian AS. Relation between diastolic left ventricular function and myocardial blood volume during adenosine-induced coronary hyperemia. Am Heart J. 129:1995;696-702.
34. Nussbacher A, Avle S, Kalil R, et al. Mechanism of adenosine-induced elevation of pulmonary capillary wedge pressure in humans. Circulation. 92:1995;371-379.
35. Chan SY, Brunken RC, Czernin J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol. 20:1992;979-985.
36. Leppo JA. Dipyridamole-thallium imaging the lazy man's stress test . J Nucl Med. 30:1989;281-287.
37. Wilson RF, White CW. Intracoronary papavarine an ideal coronary vasodilator for studies of the coronary circulation in conscious humans . Circulation. 73:1986;444-451.
38. Marchant E, Pichard A, Rodriguez JA, Casanegra P. Acute effect of systemic versus intracoronary dipyridamole on coronary circulation. Am J Cardiol. 57:1986;1401-1404.